You are here

CHAPLE disease

Regeneron’s Antibody Gets FDA Approval for Ultra-Rare Hereditary Disease

BioSpace

Sun, 08/20/23 - 05:17 pm

FDA Action Alert: Ipsen, Revance, Neurocrine and Regeneron

BioSpace

Mon, 08/14/23 - 11:29 am

Revance Therapeutics

fibrodysplasia ossificans progressiva

cervical dystonia

Huntington's disease

5 Highly Anticipated FDA Decisions for Rare Diseases Coming This Year

BioSpace

Fri, 07/28/23 - 11:46 am

fibrodysplasia ossificans progressiva

Santhera Pharmaceuticals